Position in IMTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,952,760
+$1,807,857 QoQ
Shares Held
192,770
+1300.8% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#28
of 83 holders
Holding Since
Sep 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Derivatives in IMTX
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$583,632
PutShares
50,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. IMTX ranks #21 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
81,700 | $15,300,776 | |
| 2 | GMAB |
Genmab A/S
|
420,487 | $11,550,777 | |
| 3 | TECH |
BIO-TECHNE Corp
|
125,626 | $8,875,476 | |
| 4 | IMCR |
Immunocore Holdings plc
|
274,663 | $8,720,550 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
414,005 | $7,746,033 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
305,794 | $6,791,684 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
75,588 | $6,165,713 | |
| 8 | SLDB |
Solid Biosciences Inc.
|
603,472 | $6,028,685 |
All Filings in IMTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,952,760 | 192,770 | Shares | Sole | 2026-08-14 | |
| 2023-12-31 | $144,903 | 13,761 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $583,632 | 50,400 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $583,632 | 50,400 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||